Glucose toxicity

Endocrine Reviews

Volumn 13, Issue 3, 1992, Pages 415-431

  Yki jarvinen, Hannele ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; GLUCOSE; GLUCOSE TRANSPORTER; HEXOSAMINE; INOSITOL PHOSPHATE; INSULIN; LEVO GLUCOSE; PHLORIZIN; PHOSPHOLIPASE C; PROTEIN KINASE C; STREPTOZOCIN;

ACUTE DISEASE; CHRONIC DISEASE; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT SYSTEM; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMAL; CHRONIC DISEASE; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; HUMAN; HYPERGLYCEMIA; INSULIN; SUPPORT, NON-U.S. GOV'T;

EID: 0026731869     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-13-3-415     Document Type: Article

References (193)

1. Pirart J 1978 Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 3:168-188
2. Krolewski AS, Canessa M, Warram JH, Laffei LMB, Christlieb AR, Knowler WC, Rand LI 1988 Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145
3. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Neehemias C, Smith H 1982 Infection and diabetes: the case for glucose control. Am J Med 72:439-450
4. Hostetter MK 1990 Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 39:271-275
5. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A 1989 Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219-226
6. Pugliese G 1991 Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 7:35-59
7. Greene DA, Lattimer SA, Sima AAF 1987 Sorbitol, phosphoino-sitides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606
8. Brownlee M, Cerami A, Vlassara H 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
9. Lorenzi M, Nordberg JA, Toledo S 1987 High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 36:1261-1267
10. Tesfamariam B, Brown ML, Cohen RA 1991 Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648
11. Unger RH, Grundy S 1985 Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119-121
12. Rossetti L, Giaccari A, DeFronzo RA 1990 Glucose toxicity. Diabetes Care 13:610-630
13. Yki-Järvinen H 1990 Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia 33:579-585
14. Yki-Järvinen H, Young AA, Lamkin C, Foley JE 1987 Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79:1713-1719
15. Jackson RA, Roshania RD, Hawa MI, Sim BM, DiSilvio L 1986 Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques. J Clin Endocrinol Metab 63:541-549
16. Yki-Järvinen H, Bogardus C, Howard BV 1987 Hyperglycemia stimulates carbohydrate oxidation in humans. Am J Physiol 253:E376-E382
17. Nurjhan N, Campbell P, Kennedy F, Miles J, Gerich J 1986 Insulin dose response characteristics for suppression of glycerol release and conversion to glucose in man. Diabetes 35:1326-1331
18. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
19. DeFronzo RA, Simonson D, Ferrannini E 1982 Hepatic and peripheral insulin resistance: a common feature of type 2 (noninsulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319
20. Yki-Jarvinen H, Koivisto VA 1986 Natural course of insulin resistance in type 1 diabetes. N Engl J Med 315:224-230
21. Yki-Jarvinen H, Sahlin K, Ren JM, Koivisto VA 1990 Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes 39:157-167
22. Henry RR, Gumbiner B, Flynn T, Thorburn AW 1990 Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM. Diabetes 39:149-156
23. Yki-Jarvinen H, Taskinen M-R, Kiviluoto T, Hilden H, Helve E, Koivisto VA, Nikkila E 1984 Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. J Clin Endocrinol Metab 59:1183-1192
24. Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, Clemens AH, Service FJ 1980 Control of blood sugar in insulindependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med 303:1313-1318
25. Yki-Jarvinen H, Koivisto VA 1984 Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab 58:659-666
26. Lager I, Lonnroth P, Von Schenck H, Smith U 1983 Reversal of insulin resistance in type 1 diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J 287:1001-1004
27. Yki-Jarvinen H, Helve E, Koivisto VA 1987 Hyperglycemia decreases glucose uptake in type 1 diabetes. Diabetes 36:892-896
28. Vuorinen-Markkola H, Koivisto VA, Yki-Jarvinen H 1992 Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes 41:571-580
29. Attvall S, Fowelin J, von Schenck H, Lager I, Smith U 1991 Insulin sensitivity and levels of counterregulatory hormones in IDDM—effects of euglycemia and hyperglycemia. Acta Endocrinol (Copenh) 124 [Suppl 3]:4 (Abstract)
30. Rossetti L, Shulman GI, Zawalich W, DeFronzo RA 1987 Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80:1037-1044
31. Rossetti L, Laughlin MR 1989 Correction of chronic hyperglycemia with vanadate but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84:892-899
32. Koffler M, Imamura T, Santeusanio F, Helderman JH 1988 Antecedent chronic hyperglycaemia blocks phlorizin-induced insulin resistance in the dog. Diabetologia 31:228-234
33. Katz A, Nyomba BL, Bogardus C 1988 No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. Am J Physiol 255:E942-E945
34. Marshall S 1989 Kinetics of insulin action on protein synthesis in isolated adipocytes. Ability of glucose to selectively desensitize the glucose transport system without altering insulin stimulation of protein synthesis. J Biol Chem 264:2029-2036
35. Lemmon SK, Sens DA, Buse MG 1985 Insulin stimulation of glucose transport and metabolism in a human Wilms’ tumor-derived myoblast-like cell line: modulation of hormone effects by glucose deprivation. J Cell Physiol 125:456-464
36. Sasson S, Cerasi E 1986 Substrate regulation of the glucose transport system in rat skeletal muscle. Characterization and kinetic analysis in isolated soleus muscle and skeletal muscle cells in culture. J Biol Chem 261:16827-16833
37. Sasson S, Edelson D, Cerasi E 1987 In vitro autoregulation of glucose utilization in rat soleus muscle. Diabetes 36:1041-1046
38. Mitsumoto Y, Burdett E, Grant A, Klip A 1991 Differential expression of the GLUTl and GLUT4 glucose transporters during differentiation of L6 muscle cells. Biochem Biophys Res Commun 175:652-659
39. Koranyi L, Bourey RE, Vuorinen-Markkola H, Koivisto VA, Mueckler M, Permutt MA, Yki-Järvinen H 1991 Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia 34:763-765
40. Kern M, Wells JA, Stephens JM, Elton CW, Friedman JE, Tapscott EB, Pekala PH, Dohm GL 1990 Insulin responsiveness in skeletal muscle is determined by glucose transporter (GLUT4) protein level. Biochem J 270:397-400
41. Klip A, Paguet MR 1990 Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13:228-243
42. Koivisto UM, Martinez-Valdez H, Bilan PJ, Burdett E, Ramlal T, Klip A 1991 Differential regulation of the GLUTl and GLUT4 glucose transport systems by glucose and insulin in L6 muscle cells in culture. J Biol Chem 266:2615-2621
43. Tordjman KM, Leingang KA, Mueckler M 1990 Differential regulation of the HepG2 and adipocyte/muscle glucose transporters in 3T3L1 adipocytes. Effect of chronic glucose deprivation. Biochem J 271:201-207
44. Tillotson LG, Yamada K, Isselbacher KJ 1984 Regulation of hexose transporters of chicken embryo fibroblasts during glucose starvation. Fed Proc 43:2262-2264
45. Paris S, Pouyssegur J, Ailhaud G 1980 Sugar transport in chick embryo cardiac cells in culture. Analysis by countertransport, relationship to phosphorylation and effect of glucose starvation. Biochim Biophys Acta 602: 644-652
46. Kietzien RF, Perdue JF1975 Induction of sugar transport in chick embryo fibroblasts by hexose starvation. Evidence for transcriptional regulation of transport. J Biol Chem 250:593-600
47. Yamada K, Tillotson LG, Isselbacher KI 1983 Regulation of hexose carriers in chicken embryo fibroblasts. Effect of glucose starvation and role of protein synthesis. J Biol Chem 258:9786-9792
48. Germinario RI, Kristof A, Chang Z, Manuel S 1990 Characterization of the D-allose-mediated regulation of sugar transport in Chinese hamster fibroblasts. J Cell Physiol 145:318-323
49. Haspel HC, Wilk EW, Birnbaum MJ, Cushman SW, Rosen OM 1986 Glucose deprivation and hexose transporter polypeptides of murine fibroblasts. J Biol Chem 261:6778-6789
50. Germinario RI, Roekman H, Oliveira M, Manuel S, Taylor M 1982 Regulation of sugar transport in cultured diploid human skin fibroblasts. J Cell Physiol 112:367-372
51. Walker PS, Ramlal R, Donovan JA, Doering TP, Sandra A, Kiip A, Pessin JE 1989 Insulin and glucose-dependent regulation of the glucose transport system in the rat L6 skeletal muscle cell line. J Biol Chem 264:6587-6595
52. Walker PS, Ramlal T, Sarabia V, Koivisto U-M, Bilan PJ, Pessin JE, Keip A 1990 Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. J Biol Chem 265:1516-1523
53. Maher F, Harrison LC 1990 Stabilization of glucose transporter mRNA by insulin/IGF-1 and glucose deprivation. Biochem Biophys Res Commun 171:210-215
54. Wertheimer E, Sasson S, Cerasi E 1990 Regulation of hexose transport in myocytes by glucose: possible sites of interaction. J Cell Physiol 143:330-336
55. Van Putten JPM, Krans HMJ 1985 Glucose as a regulator of insulin-sensitive hexose uptake in 3T3 adipocytes. J Biol Chem 260:7996-8001
56. Sarabia V, Ramlal T, Klip A 1990 Glucose uptake in human and animal muscle cells in culture. Biochem Cell Biol 68:536-542
57. Traxinger RR, Marshall S 1989 Role of amino acids in modulating glucose-induced desensitization of the glucose transport system. J Biol Chem 264:20910-20916
58. Traxinger RR, Marshall S 1990 Glucose regulation of insulin receptor affinity in primary cultured adipocytes. J Biol Chem 265:18879-18883
59. Garvey WT, Olefsky JM, Matthaei S, Marshall S 1987 Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem 262:189-197
60. Wertheimer E, Sasson S, Cerasi E, Ben-Neruah Y 1991 The ubiquitous glucose transporter GLUTl belongs to the glucoseregulated protein family of stress-inducible proteins. Proc Natl Acad Sci USA 88:2525-2529
61. Pelham HR 1986 Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell 46:959-961
62. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J 1988 The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332:462-464
63. Berger J, Biswas C, Vicario PP, Strout HV, Saperstein R, Pilch PF 1989 Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 340:70-72
64. Sivitz WI, DeSautel SL, Kayano T, Bell GI, Pessin JE 1989 Regulation of glucose transporter messenger RNA in insulin-deficient states. Nature 340:72-74
65. Garvey WT, Huecksteadt TP, Birnbaum MI 1989 Pretransla-tional suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus. Science 245:60-63
66. Kahn BB, Charron MI, Lodish HF, Cushman SW, Flier JS 1989 Differential regulation of two glucose transporters in adipose cells from diabetic and insulin-treated diabetic rats. J Clin Invest 84:404-411
67. Kahn BB, Shulman GI, DeFronzo RA, Cushman SW, Rossetti L Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest 87:561-570
68. Bourey RE, Koranyi L, James DE, Mueckler M, Permutt MA 1990 Effects of altered glucose homeostasis on glucose transporter expression in skeletal muscle of the rat. J Clin Invest 86:542-547
69. Dimitrakoudis D, Ramlal T, Rastogi S, Vranic M, Klip A 1991 Hyperglycemia alters the subcellular distribution of the GLUT-1 and GLUT-4 glucose transporters differentially. Diabetes 40 [Suppl 1]:292A
70. Kahn BB, Rossetti L, Lodish HF, Charron MJ 1991 Decreased in vivo glucose uptake but normal expression of GLUTl and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest 87:2197-2206
71. Yki-Jarvinen H, Vuorinen-Markkola H, Koranyi L, Bourey R, Tordjman K, Mueckler M, Permutt AM, Koivisto VA 1992 Defect in insulin action on expression of the muscle/adipose tissue glucose transporter (GLUT4) gene in skeletal muscle of type 1 diabetic patients. J Clin Endocrinol Metab, in press
72. Rodnick KI, Slot IW, Studelska DR, Hanpeter DE, Robinson LI, Geuze HI, James DE 1992 Immunocytochemical and biochemical studies of GLUT4 in rat skeletal muscle. J Biol Chem 267:6278-6285
73. Pedersen P, Bak JF, Andersen PH, Lund S, Moller DE, Flier IS, Kahn BB 1990 Evidence against altered expression of GLUTl or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865-870
74. Eriksson J, Koranyi L, Bourey R, Schalin-Jantti C, Widen E, Mueckler M, Permutt AM, Groop LC 1992 Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT4) gene in human skeletal muscle. Diabetologia 35:143-147
75. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM and NIDDM. Diabetes 41:465-475
76. Yki-Jarvinen H, Lindstrom J, Koranyi L, Bourey R, Permutt AM, Koivisto VA 1991 Pretranslational alterations in GLUT4 gene expression in type 2 diabetes irrespective of control. Diabetologia 34:A3
77. Traxinger RR, Marshall S 1991 Coordinated regulation of glutamine: fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. J Biol Chem 266:10148-10154
78. Marshall S, Bacote V, Traxinger RR 1991 Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712
79. Salter DW, Cook JS 1976 Reversible independent alterations in glucose transport and metabolism in cultured human cells deprived of glucose. J Cell Physiol 89:143-156
80. Marshall S, Baeote V, Traxinger RR 1991 Complete inhibition of glucose-induced desensitization of the glucose transport system by inhibitors of mRNA synthesis. J Biol Chem 266:10155-10161
81. Wallberg-Henriksson H, Zetan N, Henriksson J 1987 Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. J Biol Chem 262:7665-7671
82. Bjomtorp P, Berchtold P, Holm J, Larsson B 1971 The glucose uptake of human adipose tissue in obesity. Eur J Clin Invest 1:480-485
83. Bilan PJ, Klip A 1990 Glycation of the human erythrocyte glucose transporter in vitro and its functional consequences. Biochem J 268:661-667
84. Rrupka RM, Deves R 1980 Asymmetric binding of steroids to internal and external sites in the glucose carrier of erythrocytes. Biochim Biophys Acta 598:134-144
85. Harik SI, Behmand RA, Arafah BM 1991 Chronic hyperglycemia. increases the density of glucose transporters in human erythrocyte membranes. J Clin Endocrinol Metab 72:814-818
86. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE 1988 Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318:1487-1492
87. Harres M, Prout BJ 1970 Relative hypoglycaemia. Lancet 2:317
88. DeFronzo RA, Hendler R, Christensen N 1980 Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes 29:125-131
89. McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB 1986 Chronic hypoglycemia increases brain glucose transport. Am J Physiol 251:E442-E447
90. Gutniak M, Blomqvist G, Widen L, Stone-Elander S, Hamberger B, Grill V 1990 D-[U-nC]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Physiol 258:E805-E812
91. Grill V, Gutniak M, Bjorkman O, Lindqvist M, Stone-Elander S, Seitz RI, Blomqvist G, Reichard P, Widen L 1990 Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am J Physiol 258:E813-E820
92. Gjedde A, Crone C 1981 Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 214:456-457
93. Pelligrino DA, Lipa MD, Albrecht RF 1990 Regional blood-brain glucose transfer and glucose utilization in chronically hyperglycemic, diabetic rats following acute glycemic normalization. J Cereb Blood Flow Metab 10:774-780
94. McCall AL, Millington WR, Wurtman RI 1982 Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc Natl Acad Sci USA 79:5406-5410
95. Matthaei S, Horuk R, Olefsky M 1986 Blood-brain glucose transfer in diabetes mellitus. Decreased number of glucose transporters at blood-brain barrier. Diabetes 35:1181-1184
96. Walker PS, Donovan IA, Van Ness BG, Fellows RE, Pessin JE 1988 Glucose-dependent regulation of glucose transport activity, protein, and mRNA in primary cultures of rat brain glial cells. J Biol Chem 263:15594-15601
97. Pardridge WM, Boado RI, Farrell CR 1990 Brain-type glucose transporter (GLUTl) is selectively localized to the blood-brain barrier. Studies with quantitative Western blotting and in situ hybridization. J Biol Chem 265:18035-18040
98. McCall AL, Gould JB, Ruderman NB 1984 Diabetes-induced alterations of glucose metabolism in rat cerebral microvessels. Am J Physiol 247:E462-E467
99. Dohan FC, Lukens FDW 1948 Experimental diabetes produced by the administration of glucose. Endocrinology 42:244-262
100. Dimitriadis G, Cryer P, Gerich J 1985 Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A-and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose. Diabetologia 28:63-69
101. Ward WK, Halter JB, Beard JC, Porte Jr D 1984 Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 246:E405-E411
102. Flax H, Matthews DR, Levy JC, Coppack SW, Turner RC 1991 No glucotoxicity after 53 hours of 6.0 mmol/1 hyperglycaemia in normal man. Diabetologia 34:570-575
103. Leahy JL, Weir GC 1988 Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia. Diabetes 37:217-222
104. Imamura T, Koffler M, Helderman JH, Prince D, Thirlby R, Inman L, Unger RH 1988 Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia. Diabetes 37:600-609
105. Leahy JL, Cooper HE, Deal DA, Weir GC 1986 Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest 77:908-915
106. Leahy JL, Cooper HE, Weir GC 1987 Impaired insulin secretion associated with near normoglycemia. Study in normal rats with 96-h in vivo glucose infusions. Diabetes 36:459-464
107. Leahy JL, Weir GC 1991 Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level. Diabetologia 34:640-647
108. Weir GC, Clore ET, Zmaehinski CJ, Bonner-Weir S 1981 Islet secretion in a new experimental model for noninsulin-dependent diabetes. Diabetes 30:590-585
109. Starke A, Grundy S, McGarry JD, Unger RH 1985 Correction of hyperglycemia with phlorizin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes. Proc Natl Acad Sci USA 82:1544-1546
110. Collier SA, Mandel TE, Carter WM 1982 Detrimental effect of high medium glucose concentration on subsequent endocrine function of transplanted organ-cultured foetal mouse pancreas. Aust J Exp Biol Med Sci 60:437-445
111. Korsgren O, Jansson L, Andersson A 1989 Effects of hyperglycemia on function of isolated mouse pancreatic islets transplanted under kidney capsule. Diabetes 38:510-515
112. Korsgren O, Jansson L, Sandler S, Andersson A 1990 Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J Clin Invest 86:2161-2168
113. Giroix M-H, Portha B, Kergoat M, Bailbe D, Pieon L 1983 Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with noninsulin-dependent diabetes. A study with the perfused pancreas. Diabetes 32:445-451
114. Weir GC, Bonner-Weir S, Leahy JL 1990 Islet mass and function in diabetes and transplantation. Diabetes 39:401-405
115. Bolaffi JL, Rodd G, Ma YH, Grodsky GM 1990 Effect of glucagon or somatostatin on desensitized insulin secretion. Endocrinology 126:1750-1755
116. Orci L, Thorens B, Ravazzola M, Lodish HF 1989 Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains. Science 245:295-297
117. Thorens B, Sarkar HK, Kaback HR, Lodish HF 1988 Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 55:281-290
118. Permutt MA, Koranyi L, Keller K, Lacy PE, Seharp DW, Mueck-ler M 1989 Cloning and functional expression of a human pancreatic islet glucose-transporter cDNA. Proc Natl Acad Sci USA 86:8688-8692
119. m glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. J Biol Chem 265:6548-6551
120. Meglasson MD, Matschinsky FM 1986 Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev 2:163-214
121. Iynedjian PB, Pilot PR, Nouspikel T, Milburn IL, Quaade C, Hughes S, Ucla C, Newgard CB 1989 Differential expression and regulation of the glucokinase gene in liver and islets of Langer-hans. Proc Natl Acad Sci USA 86:7838-7842
122. m glucose transporters in noninsulin-dependent diabetes. Science 250:546-549
123. Orci L, Unger RH, Ravazzola M, Ogawa A, Komiya I, Baetens D, Lodish HF, Thorens B 1990 Reduced β-cell glucose transporter in new onset diabetic BB rats. J Clin Invest 86:1615-1622
124. Thorens B, Weir GC, Leahy IL, Lodish HF, Bonner-Weir S 1990 Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats. Proc Natl Acad Sci USA 87: 6492-6496
125. Tiedge M, Lenzen S 1991 Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic β-cells. Biochem J 279:899-901
126. Chen L, Alam T, Johnson JH, Hughes S, Newgard CB, Unger RH 1990 Regulation of β-cell glucose transporter gene expression. Proc Natl Acad Sci USA 87:4088-4092
127. Yasuda K, Yamada Y, Inagaki N, Yano H, Okamoto Y, Tsuji K, Fukumoto H, Imura H, Seino S, Seino Y 1992 Expression of GLUTl and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes 41:76-81
128. Metz SA 1991 The pancreatic islet as Rubik’s cube. Is phospholipid hydrolysis a piece of the puzzle? Diabetes 40:1565-1573
129. TYirk J, Wolf BA, McDaniel ML 1987 The role of phospholipid-derived mediators including arachidonic acid, its glucose-induced insulin secretion by pancreatic islets. Prog Lipid Res 26:125-181
130. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248
131. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306:67-69
132. 2+ from rat insulinoma microsomes by inositol-1,4,5-trisphosphate. Nature 309:562-564
133. Nishizuka Y 1984 The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693-698
134. Bell RM 1986 Protein kinase C activation by diacylglycerol second messengers. Cell 45:631-632
135. Dunlop ME, Larkins RG 1985 Pancreatic islets synthesize phospholipids de novo from glucose via acyl-dihydrozyacetone phosphate. Biochem Biophys Res Commun 132:467-473
136. Peter-Riesch B, Fathi M, Sehlegel W, Wollheim CB 1988 Glucose and carbachol generate 1,2-diacylglycerols by different mechanisms in pancreatic islets. J Clin Invest 81:1154-1161
137. Zawalich WS, Zawalich KC, Shulman GI, Rossetti L1990 Chronic in vivo hyperglycemia impairs phosphoinositide hydrolysis and insulin release in isolated perifused rat islets. Endocrinology 126:253-260
138. Sako Y, Grill VE 1990 Coupling of β-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 39:1580-1583
139. Robertson RP 1988 Eicosanoids as pluripotential modulators of pancreatic islet function. Diabetes 37:367-370
140. Madsbad S 1983 Prevalence of residual B cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes. Diabetologia 24:141-147
141. Yki-Järvinen H, Koivisto VA 1984 Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab 59:371-378
142. Ginsberg HN 1977 Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapy. Metabolism 26:1135-1146
143. Bratusch-Marrain PR, DeFronzo RA 1983 Impairment of insulin mediated glucose metabolism by hyperosmolality in man. Diabetes 32:1028-1034
144. DeFronzo RA, Beckles AD 1979 Glucose intolerance following chronic metabolic acidosis in man. Am J Physiol 236:E328-E334
145. DeFronzo RA, Lang R 1980 Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. N Engl J Med 303:1259-1263
146. Yajnik CS, Smith RF, Hockaday TDR, Ward NI 1984 Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J 288:1032-1034
147. Randle PJ, Garland PB, Hales CN, Newsholme EA 1963 The glucose fatty acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789
148. Yki-Järvinen H, Taskinen M-R 1991 Interrelationships among insulin’s antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 37:1271-1278
149. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS 1984 Differential sensitivity to β-cell secretagogues in “early” type 1 diabetes mellitus. Diabetes 33:516-521
150. Agner T, Damm P, Binder C 1987 Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients. Diabetes Care 10:164-169
151. Krarup T, Madsbad S 1986 Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus. Diabete Metab 12:256-260
152. Knip M, Ilonen J, Mustonen A, Äkerblom HK 1986 Evidence of an accelerated B-cell destruction in HIA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes. Diabetologia 29:347-351
153. Revers RR, Kolterman OG, Scarlett JA, Gray RS, Olefsky JM 1984 Lack of in vivo insulin resistance in controlled insulindependent, type I, diabetic patients. J Clin Endocrinol Metab 58:353-358
154. Arslanian S, Nixon PA, Becker D, Drash ALD 1990 Impact of physical fitness and glycemic control on insulin action in adolescents with IDDM. Diabetes Gare 13:9-15
155. Beck-Nielsen H, Richelsen B, Häsling G, Nielsen OH, Heding L, Sorensen NS 1984 Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes 33:832-837
156. DeFronzo RA 1985 Improved insulin sensitivity in patients with type 1 diabetes mellitus after GSII. Diabetes 34 [Suppl 3]:80-86
157. Kruszynska YT, Petranyi G, Home PD, Taylor R, Alberti KGMM 1986 Muscle enzyme activity and insulin sensitivity in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29:699-705
158. Reaven G, Miller R 1968 Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 17:560-569
159. Welborn TA, Stenhouse NS, Johnson CJ 1969 Factors determining serum insulin response in a population sample. Diabetologia 5:263-266
160. Savage PJ, Dippe SE, Bennett PH, Gorden P, Roth J, Rushforth NB, Miller M 1975 Hyperinsulinemia and hypoinsulinemia: insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes 24:362-368
161. Zimmet P, Whitehouse S, Alford F, Chisholm D 1978 The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia 15:23-27
162. Reaven GM, Miller RG 1979 An attempt to define the nature of chemical diabetes using a multidimensional analysis. Diabetologia 16:17-24
163. Zimmet P, Whitehouse S, Kiss J 1979 Ethnic variability in the plasma insulin response to oral glucose in Polynesian and Micronesian subjects. Diabetes 28:624-628
164. Martin FIR, Wyatt GB, Griew AR, Haurahelia M, Higginbotham L 1980 Diabetes mellitus in urban and rural communities in Papua, New Guinea: studies of prevalence and plasma insulin. Diabetologia 18:369-374
165. Haffner SM, Stem MP, Hazuda HP, Mitchell BD, Patterson IX 1988 Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319:1297-1301
166. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L 1989 Early metabolic defects in persons at increased risk of non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343
167. Sicree RA, Zimmet PZ, King HOM, Coventry JS 1987 Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36:179-186
168. Lillioja S, Mott DM, Howard V, Bennett PH, Yki-Järvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C 1988 Impaired glucose tolerance as a disorder of insulin action-longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225
169. Saad F, Knowler C, Pettit J, Nelson G, Mott M, Bennett H 1989 Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1:1356-1359
170. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR 1990 Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915
171. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WGH, Knowler WC, Bennett PH, Moll P, Bogardus C 1987 In vivo insulin action is a familial characteristic in non-diabetic Pima Indians. Diabetes 36:1329-1335
172. Bogardus G, Lillioja S, Nyomba BL, Zurlo F, Swinbum B, Esposito-Del Puente A 1989 Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 38:1423-1432
173. Firth RG, Bell PM, Rizza PA 1986 Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulindependent diabetes mellitus. N Engl J Med 314:1280-1286
174. Yki-Järvinen H, Puhakainen I, Saloranta G, Groop L, Taskinen M-R 1991 Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260:E680-E689
175. Groop L, Widen E, Franssila-Kallunki A, Ekstrand A, Saloranta G, Schalin G, Eriksson J 1989 Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32:599-605
176. Shulman GI, Rothman DL, lue T, Stein P, DeFronzo PA, Shul-man RG 1990 Quantitation of muscle glycogen synthesis in normal subjects and subjects with noninsulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-238
177. Freidenberg GR, Reichart D, Olefsky IM, Henry RR 1988 Reversibility of defective adipocyte insulin receptor kinase activity in noninsulin-dependent diabetes mellitus. J Clin Invest 82:1398-1406
178. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG 1985 The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222-234
179. Scarlett JA, Gray RS, Griffin J, Olefsky JM, Kolterman OG 1982 Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 5:353-363
180. Yki-Järvinen H, Nikkilä E, Helve E, Taskinen M-R 1988 Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 84:185-192
181. Henry RR, Wallace P, Olefsky IM 1986 Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 35:990-998
182. Bogardus G, Ravussin E, Robbins DG, Wolfe RR, Horton ES, Sims EAH 1984 Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 33:311-318
183. Bogardus G, Lillioja S, Howard BV, Reaven G, Mott D 1984 Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulindependent diabetic subjects. J Clin Invest 74:1238-1246
184. Stanik S, Marcus R 1980 Insulin secretion improves following dietary control of plasma glucose in severely hyperglycemic obese patients. Metabolism 29:346-350
185. Kosaka K, Kuzuya T, Akanuma Y, Hagura R 1980 Increase in insulin response after treatment of overt maturity-onset diabetes is dependent on the mode of treatment. Diabetologia 18:23-28
186. Savage PJ, Bennion LJ, Bennett PH 1979 Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy. J Clin Endocrinol Metab 49:830-833
187. Eriksson K-F, Lindgärde F 1991 Prevention of type 2 (noninsulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 34:891-898
188. Zawadzki JK, Bogardus C, Foley JE 1987 Insulin action in obese non-insulin-dependent diabetics and in their isolated adipocytes before and after weight loss. Diabetes 36:227-236
189. Vague P, Moulin J-P 1982 The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Metabolism 31:139-142
190. Andrews WI, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven GM 1984 Insulin therapy in obese, non-insulindependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33:634-642
191. Hidaka H, Nagulesparan M, Klimes I, Clark R, Sasaki H, Aronoff SA, Vasquez B, Rubenstein AH, Unger RH 1982 Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. J Clin Endocrinol Metab 54:217-222
192. Ginsberg H, Rayfield EJ 1981 Effect of insulin therapy on insulin resistance in type II diabetic subjects. Diabetes 30:739-745
193. Simonson DC, Del Prato S, Castellino P, Groop L, DeFronzo RA 1987 Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients. Diabetes 36:136-146